Clinical trials
Active, not recruiting trials in the Netherlands with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
182 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 7 |
| 2019 | 15 |
| 2020 | 16 |
| 2021 | 28 |
| 2022 | 30 |
| 2023 | 22 |
| 2024 | 23 |
| 2025 | 11 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 182 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 15 |
| Erasmus Medical Center | 13 |
| Maastricht University Medical Center | 7 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 6 |
| Amsterdam UMC, location VUmc | 6 |
| Abbott Medical Devices | 5 |
| The Netherlands Cancer Institute | 5 |
| UMC Utrecht | 5 |
| Leiden University Medical Center | 4 |
| Medtronic Cardiovascular | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 15 |
| Coronary Artery Disease | 12 |
| Aortic Valve Stenosis | 9 |
| Atrial Fibrillation | 9 |
| Breast Neoplasms | 7 |
| Prostatic Neoplasms | 6 |
| Cardiovascular Diseases | 5 |
| Hypertension | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Stroke | 5 |
Trials
Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.
82 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.